10x Genomics acquired Proteintech Genomics to strengthen its proteomics toolkit for single-cell and spatial multiomics workflows. The companies said the deal is intended to combine Proteintech’s protein detection capabilities with 10x’s scalable single-cell and spatial platforms. The acquisition targets a growing customer need for harmonizing RNA and protein measurements, and it expands 10x’s ability to deliver multiplexed antibody-based panels alongside transcriptomic assays. Proteintech Genomics’ technology includes an antibody-based discovery panel designed to support ready integration into 10x workflows. 10x said the move will streamline product development and align proteomics tools under one organization, aiming to increase scale, pricing competitiveness, and quality controls for multiomics experiments. The companies did not disclose deal terms.